ANROVSGTBP• 3 Months (Normalized)
ANRO vs GTBP (Alto Neuroscience Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1291.7%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1291.7 pts
GTBP outperforming by 1291.70 percentage points
ANROGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | ANRO Price | ANRO Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $6.88 | +1291.70% | - | |
| Sep 28, 2026 | $- | $6.80 | +1276.52% | - | |
| Sep 25, 2026 | $- | $6.89 | +1294.74% | - | |
| Sep 24, 2026 | $- | $6.83 | +1282.59% | - | |
| Sep 23, 2026 | $27.50 | +10.26% | $7.10 | +1337.25% | -1326.99% |
| Sep 22, 2026 | $30.78 | +23.42% | $- | - | |
| Sep 21, 2026 | $30.63 | +22.81% | $7.18 | +1353.44% | -1330.63% |
| Sep 18, 2026 | $30.27 | +21.37% | $7.16 | +1349.39% | -1328.02% |
| Sep 17, 2026 | $30.98 | +24.22% | $7.49 | +1416.19% | -1391.97% |
| Sep 16, 2026 | $30.00 | +20.29% | $7.81 | +1480.97% | -1460.68% |
| Sep 15, 2026 | $30.25 | +21.29% | $9.00 | +1721.86% | -1700.57% |
| Sep 14, 2026 | $31.68 | +27.02% | $11.63 | +2254.25% | -2227.23% |
| Sep 11, 2026 | $32.00 | +28.31% | $8.61 | +1642.91% | -1614.60% |
| Sep 10, 2026 | $31.68 | +27.02% | $6.18 | +1151.01% | -1123.99% |
| Sep 09, 2026 | $34.07 | +36.61% | $5.98 | +1110.53% | -1073.92% |
Page 1 of 5